Colonoscopy is performed routinely for colorectal cancer (CRC) screening, follow-up of
other abnormal screening tests, workup of signs and symptoms of gastrointestinal disease …

Background & Aims Most colorectal cancers (CRC) arise from colorectal adenomas, yet
there is not enough information on global prevalence to inform health care policy. We …

Whether ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers
modify colorectal cancer risk remains controversial. We aimed to determine association …

The incidence of colorectal polyps is rising. Certain types of polyps are considered to be the
precursor lesions for colorectal cancers. To investigate the prevalence and related factors of …

Introduction Survival for colorectal cancer is improved by earlier detection. Rapid
assessment and diagnostic demand have created a surge in two-week rule referrals and …

Background Although nonsteroidal anti‐inflammatory drugs (NSAIDs) reduce colorectal
cancer (CRC) risk, their role in preventing post‐colonoscopy CRC (PCCRC) remains …

BACKGROUND In resource-limited countries, risk stratification can be used to optimize
colorectal cancer screening. Few prospective risk prediction models exist for advanced …

Background Evolving epidemiological data, backed by mechanistic evidence, supports a
paradoxical increase in the risk of colorectal cancer after Roux-en-Y gastric bypass surgery …

Background: Colorectal cancer (CRC) is the fourth leading cause of cancer-related death in
the United States, despite being largely preventable and treatable. Improving overall …

Purpose. Evidence from industrialized/developed countries showed that colorectal cancer
(CRC) incidence rates have significantly dropped due to the widespread use of …